Your Guide to Hip Replacement Surgery . What Is a Hip Replacement? The hip is one of the largest joints in the body and is shaped as a ball and socke ...

While compounded medications like this one use ingredients that are Food and Drug Administration ... to compare pharmacy options, GoodRx is available to help you search online to find cheaper ...

GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today released a new report, The Prescription Drug Gender Divide, detailing how women shoulder a significantly greater ...

SANTA MONICA, Calif., February 18, 2025--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading medication savings platform in the U.S., today announced its drug savings platform residing with Amazon ...

Q4 2024 Earnings Call Transcript February 27, 2025 GoodRx Holdings, Inc. misses on earnings expectations. Reported EPS is $0.09 EPS, expectations were $0.1. Operator: Ladies and gentlemen, thank you ...

SANTA MONICA, Calif., February 18, 2025--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading medication savings platform in the U.S., today announced its drug savings platform residing with Amazon Web ...

And this is not coming at the expense of GoodRx's aligned economics, but through a combination of cost plus reimbursement, pricing partnership, and brand drug solutions. As an example, deep ...

Commercial insurance coverage of blockbuster GLP-1 drugs has not expanded much over the past year, despite growing demand and expanded indications, according to a new report from GoodRx. Data from ...

Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results tomorrow before the bell. Here’s what investors should know. GoodRx met analysts’ revenue expectations last ...

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

In a report released yesterday, Sean Dodge from RBC Capital maintained a Buy rating on GoodRx Holdings (GDRX – Research Report), with a price ...

A groundbreaking new study suggests that sotagliflozin, a drug recently approved to treat type 2 diabetes and kidney disease in people with additional cardiovascular risk factors, can also ...